| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinical Strategies in the Management of Biochemical Recurrence After Radical Prostatectomy
|
Zimmerman, Robert A.
|
|
2003
|
2 |
3 |
p. 160-166
7 p.
|
artikel
|
| 2 |
Comparison of Total Prostate-Specific Antigen and Derivative Levels in a Screening Population of Black, White, and Korean-American Men
|
Park, Jae
|
|
2003
|
2 |
3 |
p. 173-176
4 p.
|
artikel
|
| 3 |
Complications of Androgen-Deprivation Therapy for Prostate Cancer
|
Holzbeierlein, Jeffrey M.
|
|
2003
|
2 |
3 |
p. 147-152
6 p.
|
artikel
|
| 4 |
Highlights from the XII European Cancer Conference; Copenhagen, Denmark, September 21-25, 2003
|
Tyagi, Preeta
|
|
2003
|
2 |
3 |
p. 137-141
5 p.
|
artikel
|
| 5 |
Ion Channels as Molecular Targets in Prostate Cancer
|
Trepel, Jane B.
|
|
2003
|
2 |
3 |
p. 188-189
2 p.
|
artikel
|
| 6 |
Mutations in Ribonuclease L Gene Do NotOccur at a Greater Frequency in Patients with Familial Prostate Cancer Compared with Patients with Sporadic Prostate Cancer
|
Downing, Sean R.
|
|
2003
|
2 |
3 |
p. 177-180
4 p.
|
artikel
|
| 7 |
The Anti-HER2 Monoclonal Antibody Pertuzumab May Be Effective in Androgen-Independent Prostate Cancer
|
DeGrendele, Heather
|
|
2003
|
2 |
3 |
p. 143-145
3 p.
|
artikel
|
| 8 |
The Combination of Antiangiogenic and Cytotoxic Agents in the Treatment of Prostate Cancer
|
Retter, Avi S.
|
|
2003
|
2 |
3 |
p. 153-159
7 p.
|
artikel
|
| 9 |
Therapeutic Approaches Targeting Prostate Cancer Progression Using Novel Voltage-Gated Ion Channel Blockers
|
Sikes, Robert A.
|
|
2003
|
2 |
3 |
p. 181-187
7 p.
|
artikel
|
| 10 |
Weekly Docetaxel in Elderly Patients with Prostate Cancer: Efficacy and Toxicity in Patients Aged ≥ 70 Years Compared with Patients Aged < 70 Years
|
Beer, Tomasz M.
|
|
2003
|
2 |
3 |
p. 167-172
6 p.
|
artikel
|
Tijdschrift beschrijving